Check Cap (CHEK) Coverage Initiated by Analysts at Dougherty & Co

Dougherty & Co started coverage on shares of Check Cap (NASDAQ:CHEK) in a research report report published on Tuesday morning, The Fly reports. The brokerage issued a buy rating and a $6.00 price target on the medical research company’s stock.

A number of other equities research analysts also recently weighed in on the stock. HC Wainwright set a $14.00 price objective on shares of Check Cap and gave the company a buy rating in a research report on Friday, December 14th. Zacks Investment Research downgraded shares of Check Cap from a hold rating to a sell rating in a research report on Thursday, January 3rd.

Shares of NASDAQ:CHEK opened at $2.29 on Tuesday. Check Cap has a fifty-two week low of $1.62 and a fifty-two week high of $19.78. The stock has a market cap of $3.66 million and a P/E ratio of -0.36.

Check Cap (NASDAQ:CHEK) last announced its quarterly earnings data on Monday, November 5th. The medical research company reported ($0.50) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.53) by $0.03. On average, research analysts expect that Check Cap will post -2.57 earnings per share for the current year.

A hedge fund recently bought a new stake in Check Cap stock. Dimensional Fund Advisors LP bought a new stake in shares of Check Cap Ltd (NASDAQ:CHEK) in the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 35,131 shares of the medical research company’s stock, valued at approximately $141,000. Dimensional Fund Advisors LP owned 2.20% of Check Cap as of its most recent SEC filing. 1.55% of the stock is owned by institutional investors.

About Check Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface.

Read More: Net Margin – Understanding the Different Kinds of Profit

The Fly

Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply